Crossmark

Iliac vein stenosis after implantation of a central arteriovenous coupler device in the treatment of therapy resistant arterial hypertension

Crossref DOI link: https://doi.org/10.1038/s41371-018-0090-x

Published Online: 2018-07-23

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosseel, Liesbeth https://orcid.org/0000-0002-3940-3072
Scott, Benjamin

Balmforth, Peter

Sobotka, Paul

Sievert, Horst
License Information

Text and Data Mining valid from 2018-07-23
More Information

Article History

Received: 1 May 2018

Revised: 1 July 2018

Accepted: 4 July 2018

First Online: 23 July 2018

Compliance with ethical standards

:

: PB is employed at ROX Medical. PS is employed at ROX Medical. HS has received study honoraria, consulting fee or travel expenses of 4tech Cardio, Abbott, Ablative Solutions, Ancora Heart, Bavaria Medizin, Technologie GmbH, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, Celonova, Cibiem, CGuard, Comed B.V., Contego, CVRx, Edwards, Endologix, Hemoteq, InspireMD, Lifetech, Maquet Getinge Group, Medtronic, Mitralign, Nuomao Medtech, Occlutech, pfm Medical, Recor, Renal Guard, Rox Medical, Terumo, Vascular Dynamics, Vivasure Medical, Venus, Veryan. The other authors declare that they have no conflict of interest.